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ABSTRACT
Background While various measures of common
mental disorders (CMD) have been found to be
associated with mortality, a comparison of how different
measures predict mortality may improve our
understanding of the association. This paper compares
how the Hospital Anxiety and Depression Scale (HADS)
and the 30-item General Health Questionnaire (GHQ-30)
predict all cause and cause-speciﬁc mortality.
Methods Data on 2547 men and women from two
cohorts, aged approximately 39 and 55 years, from the
West of Scotland Twenty-07 Study who were followed
up for mortality over an average of 18.9 (SD 5.0) years.
Scores were calculated for HADS depression (HADS-D),
HADS Anxiety (HADS-A) and GHQ-30. Cox Proportional
Hazards Models were used to determine how each CMD
measure predicted mortality.
Results After adjusting for serious physical illness,
smoking, social class, alcohol, obesity, pulse rate and
living alone, HRs (95% CI) per SD increase in score for
all-cause mortality were: 1.15 (1.07 to 1.25) for HADS-
D; 1.13 (1.04 to 1.23) for GHQ-30 and 1.05 (0.96 to
1.14) for HADS-A. After the same adjustments,
cardiovascular disease mortality was also related to
HADS-D (HR 1.24 (1.07 to 1.43)), to GHQ-30 (HR 1.24
(1.11 to 1.40)) and to HADS-A (HR 1.15 (1.01 to
1.32)); respiratory mortality to GHQ-30 (HR 1.33 (1.13
to 1.55)) and mortality from other causes, excluding
injuries, to HADS-D (HR 1.28 (1.05 to 1.55)).
Conclusions There were associations between CMD
and both all-cause and cause-speciﬁc mortality which
were broadly similar for GHQ-30 and HADS-D and were
still present after adjustment for important confounders
and mediators.
INTRODUCTION
The Hospital Anxiety and Depression Scale
(HADS)1 and the 30-item General Health
Questionnaire (GHQ-30)2 are two self-completion
inventories used in population surveys as measures
of common mental disorders (CMD). While both
have been shown to predict mortality3–8 each has
different qualities that could inﬂuence the associ-
ation: while the 30-item GHQ was designed to
screen for general psychiatric disorders, including
anxiety and depression, HADS consists of two
seven-item subscales, each designed speciﬁcally to
discriminate between anxiety and depression.
Anxiety and depression have shown different asso-
ciations with mortality,5 9 but it is not known how
a general measure of CMD such as GHQ-30 would
compare. There may be other differences between
the two instruments that could affect their associ-
ation with mortality: although both ask about the
recent past, unlike HADS, the ‘as usual’ wording of
GHQ may limit its ability to capture chronic
CMD; even though each has been designed to be
unaffected by physical symptoms,1 2 GHQ in par-
ticular has been criticised as containing items relat-
ing to physical symptoms.10 Any differences or
similarities observed may help shed light on the
mechanisms linking CMD to mortality.
In order to investigate any differences or similarities
between the instruments, we conducted a systematic
and simultaneous comparison of the relationship of
GHQ-30 and HADS with mortality using data from
the West of Scotland Twenty-07 Study.
METHODS
Participants
The Twenty-07 Study11 followed men and women in
three age cohorts—born around 1932, 1952 and
1972—for 20 years. It has two subsamples: the
regional sample, a two-stage stratiﬁed random sample
of people living in the Central Clydeside
Conurbation, West of Scotland and the localities
sample of people from two areas of the city of
Glasgow. Of those who agreed to have their contact
details passed from the local authority to the Medical
Research Council, 87% took part in Wave 1 inter-
views conducted in 1987/1988; the achieved sample
was 4510 (target 1500 per cohort). The second wave
was conducted in 1990–1992, with 86% of those
issued taking part. Ethical approval for Wave 1 was
granted by the ethics subcommittee of the West of
Scotland Area Medical Committees and the GP
Sub-Committee of Greater Glasgow Health Board;
the latter also approved Wave 2. Written consent was
given for each wave. Cohort members are ﬂagged
with the Scottish National Health Service Central
Registry for mortality follow-up: which provides
International Classiﬁcation of Diseases (ICD) codes
for cause of death. Wave 1 respondents have been
shown to be representative of the general population
of the sampled area.12
The data used here are from the two older
cohorts and baseline is the ﬁrst wave in which data
on both GHQ-30 and HADS were available: for
the 1930s cohort it is Wave 1, when they were
aged around 55 years, and for the 1950s cohort it
is Wave 2, when they were aged around 39 years.
Figure 1 illustrates the numbers included from each
of these cohorts.
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Mortality
As of June 2011, participants had been followed up for a
maximum of 23.2 years (mean 18.9 years, SD 5.0). The mortal-
ity outcomes used were: all-cause mortality; cardiovascular dis-
eases (CVD): (ICD) 9 codes 390–459.9; ICD 10 codes: I00–
I99; respiratory diseases: ICD 9 codes 460–519.9; ICD 10
codes: J00–J99.8; all cancers: ICD 9 codes 140–239.9; ICD 10
codes: C00–D48.9 and injuries: ICD 9 codes 800–999; E800–
E999; ICD 10 codes: S00–T983; V01–Y98.
Measures of common mental disorder
The HADS1 was designed for use in a non-psychiatric hospital
setting but has been used in other clinical and general popula-
tion settings, and correlated well with interview-based measures
and other screening questionnaires that identify psychiatric dis-
tress.13 It contains 14 items selected to be relatively unaffected
by physical illness1 and has two subscales: anxiety and depres-
sion, each with seven items scored on a four-point scale
between zero and three, creating a maximum score of 21 on
each subscale. If only one item on a subscale was missing, its
value was inferred as the mean of the available six items.14
Continuous scores were used for all analyses. HADS anxiety
covers anxious mood, restlessness and anxious thoughts but not
the somatic symptoms of anxiety; HADS depression focuses on
loss of interest and diminished pleasure response.1
The GHQ-30,2 a self-administered inventory designed to be
used in the general population and within non-psychiatric clin-
ical settings, comprises 30 questions, covering a range of neur-
otic symptoms with an emphasis on those typical of anxiety and
depression with a deliberate avoidance of those that might also
reﬂect physical illness. The responses are made on a four-point
scale between zero and three. For all analyses, continuous scores
were used and these were calculated by summing (potential
range 0–90). Missing items were scored zero15 and a maximum
of ﬁve were allowed to be missing. The GHQ-30 focuses on
inability to carry out normal functions and the appearance of
new and distressing phenomena and due to the ‘as usual’
wording is sensitive to short term rather than chronic
disorders.2
Baseline covariates
Covariates were chosen based on related literature including
reviews16–20 and individual studies7 8 21–23 and on consideration
of the likely mechanisms linking CMD to mortality.24 25
Potential confounders were sex, age (cohort), serious physical
illness and social class; and potential mediators were health
behaviours: smoking, alcohol consumption, pulse rate, obesity
and living alone, which may also be confounders. Serious phys-
ical illness was measured as the reported number (none, one,
two or more) of any of the following conditions which were
classiﬁed using Royal College of General Practitioners codes26:
CVD (1940–1950, 2100–2115), hypertension (1910), diabetes
(720), serious respiratory conditions (2475, 2490, 2495, 2505,
2510, 2515, 2520, 2525, 2530) and any cancer (0400–0590).
The conditions were obtained from the open-ended responses
to a series of prompts on longstanding illness, disability or
inﬁrmity; other serious health problems; mental health problems
and from a categorical list of common conditions. Social class
was measured by occupation, coded according to the Registrar
General’s 1980 classiﬁcation27 for current or previous occupa-
tion of the respondent or their partner using the highest status
class and dichotomised into manual and non-manual. Smokers
were classiﬁed as never, ex or current smokers. Alcohol con-
sumption was asked using a 7-day recall table and categorised
into non-drinkers, safe drinkers and binge drinkers (consuming
half the recommended weekly limit in 1 day: seven or more
units per day for women, 10 or more for men).28 Using height
and weight measured by the nurse, body mass index (BMI) was
calculated and those with a BMI of 30 or more were classiﬁed
as obese. Owing to the lack of consistent physical activity data
across the two cohorts at baseline, pulse rate in beats per minute
which was measured by the nurse was used as a proxy for phys-
ical activity/ﬁtness.29 Living alone was a dichotomous variable
based on the number of people in the household.
STATISTICAL METHODS
Baseline characteristics of participants, and Spearman rank cor-
relations between GHQ-30 and HADS scores were obtained
using SPSS V.19.
Using STATA V.11.0, Cox Proportional Hazards models were
run with age at death, or age at June 2011 if still alive, as the
time variable. Robust SEs were calculated and a dummy variable
for locality included in all models to allow for the complex
sample design. The proportional hazards assumption was
checked using a test based on Schoenfeld residuals and was
found to hold for all measures of CMD and for all covariates
except cohort, so the Cox regression analyses were stratiﬁed by
cohort using STATA’s strata subcommand. Interactions with
cohort, sex and with serious physical illness were considered
plausible and investigated. Non-linear (quadratic) relationships
between each measure of CMD and mortality were tested, but
none were signiﬁcant (so results not shown). Each measure of
CMD was transformed into z-scores so that the HRs were on a
similar scale and therefore more comparable across measures
and the results presented as the HR per SD in score. Covariates
were added to the model cumulatively in order to understand
Figure 1 Flow of Study Members through the West of Scotland
Twenty-07 Study, 1930s and 1950s cohort.
Hannah MK, et al. J Epidemiol Community Health 2013;67:558–563. doi:10.1136/jech-2012-201927 559
Research report
their effect on the CMD and mortality association: potential
confounders were added before potential mediators: model (1)
adjusted for cohort and sex; then serious illness was added:
model (2); then social class was added: model (3); then smoking
was added: model (4); and binge drinking, obesity, pulse and
living alone were added for the fully adjusted model: model (5).
To assess the impact of missing data among those with available
CMD data, the basic relationships were compared for those
with and without missing covariates.
RESULTS
Of the 2995 individuals from the 1930s and 1950s cohorts of
the Twenty-07 Study, 2776 were screened at ‘baseline’ (ie, Wave
1 for the 1930s cohort and Wave 2 for the 1950s cohort), and
of these the 2547 with complete data for all measures were
included in the analysis (ﬁgure 1). Those with missing data were
more likely to be in the 1930s cohort, to have died, and to be
in the manual social classes. A sensitivity analysis in those with
CMD measures showed a similar association between CMD and
mortality for those with and without missing covariates (results
available on request). Table 1 shows the baseline characteristics
of participants by vital status, and by GHQ-30, HADS-D and
HADS-A scores: of the 2547 individuals, 687 (27%) had died
in the follow-up period. These were more likely to be men and
to be in the 1930s cohort. The mean scores of the CMD mea-
sures are shown in table 1. The Spearman rank correlations
with GHQ-30 were: for HADS-D, 0.570 (p<0.001) and for
HADS-A, 0.630 (p<0.001).
For all-cause mortality, the HRs per SD increase in CMD
score are reported in table 2. After adjustment for sex and
cohort, all the measures of CMD were signiﬁcantly related to
all-cause mortality, with similar HRs for HADS-D and
GHQ-30, and the HR for the speciﬁc measure of anxiety,
HADS-A, the smallest. Adjustment for the covariates attenuated
the HRs, with most attenuation due to serious illness or
smoking and with social class being the next most important.
Serious illness attenuated the HRs most for HADS-D and
GHQ-30, while smoking attenuated them most for
HADS-A. After full adjustment the HRs for HADS-D and
GHQ-30 were still similar and the smallest HR for HADS-A was
no longer signiﬁcant. The only signiﬁcant interaction was
between HADS-A and sex: in subgroup analyses for HADS-A
the fully adjusted HR for men was 1.16 (95% CI 1.02 to 1.32),
comparable in magnitude with the HR for HADS-D, and for
women was not signiﬁcant (HR 0.94 (95% CI 0.85 to 1.03)).
For cause-speciﬁc mortality, the number of deaths from each
cause and the HRs per SD increase in scores are reported in
table 3 with only Models (1) and (5) shown. After full
Table 1 Baseline characteristics of participants according to vital status and CMD scores
All Died GHQ-30 HADS-A HADS-D
Baseline covariates N (%) N (%) Mean (SD) Mean (SD) Mean (SD)
All 2547 (100) 687 (27.0) 25.3 (10.8) 7.6 (3.9) 4.3 (3.1)
Sex
Men 1143 (44.9) 368 (32.2) 24.4 (10.7) 6.9 (3.8) 4.2 (3.1)
Women 1404 (55.1) 319 (22.7) 26.0 (10.9) 8.1 (4.0) 4.4 (3.1)
Cohort
1950s 1163 (45.7) 83 (7.1) 24.4 (10.9) 7.4 (3.8) 3.9 (3.0)
1930s 1384 (54.3) 604 (43.6) 26.0 (10.8) 7.8 (4.0) 4.7 (3.2)
Serious illness
None 2094 (82.2) 451 (21.5) 24.5 (10.4) 7.4 (3.9) 4.1 (3.0)
One 380 (14.9) 186 (48.9) 27.8 (12.0) 8.0 (4.0) 5.1 (3.4)
Two or more 73 (2.9) 50 (68.5) 32.8 (12.6) 9.4 (3.8) 6.6 (3.3)
Social class
Non-manual 1564 (61.4) 310 (19.8) 24.0 (9.6) 7.2 (3.7) 3.9 (2.9)
Manual 983 (38.6) 377 (38.4) 27.3 (12.3) 8.1 (4.2) 5.0 (3.4)
Smoker
Never 923 (36.2) 141 (15.3) 23.8 (9.8) 3.9 (2.9) 7.1 (3.7)
Ex 535 (21.0) 132 (24.7) 24.6 (10.4) 4.1 (3.0) 7.2 (3.9)
Current 1089 (42.8) 414 (38.0) 26.9 (11.7) 4.8 (3.3) 8.1 (4.1)
Binge drinking
Non-drinkers 788 (30.9) 229 (29.1) 26.8 (12.2) 4.8 (3.4) 7.9 (4.2)
Not binge drinkers 1325 (52.0) 314 (23.7) 24.2 (9.7) 4.0 (2.9) 7.3 (3.7)
Binge drinkers 434 (17.0) 144 (33.2) 25.8 (11.0) 4.4 (3.2) 7.6 (4.0)
Obese (BMI≥30)
No 2163 (84.9) 567 (26.2) 25.2 (10.9) 4.2 (3.2) 7.6 (3.9)
Yes 384 (15.1) 120 (31.3) 25.6 (10.6) 4.7 (3.0) 7.4 (3.9)
Lives alone
No 2286 (89.8) 585 (25.6) 24.9 (10.6) 4.3 (3.1) 7.5 (3.9)
Yes 261 (10.2) 102 (39.1) 28.3 (12.1) 4.8 (3.5) 8.5 (4.3)
Pulse mean (SD)
All 71.0 (9.8) Correlation: 0.087 0.079 0.050
Alive 70.0 (9.5)
Died 73.8 (10.0)
BMI, body mass index; CMD, common mental disorder; GHQ-30, 30-item General Health Questionnaire; HADS, Hospital Anxiety and Depression Scale.
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adjustment there were signiﬁcant HRs for CVD mortality and
all CMD measures with HRs for HADS-D and GHQ-30 being
largest, and the smallest HR was for HADS-A. For respiratory
mortality there was a signiﬁcant association after full adjustment
with GHQ-30 but with neither of the HADS measures. For
cancer mortality there was no signiﬁcant association with any of
the CMD measures with all HRs around one. Although
numbers are small, results are reported for mortality from injur-
ies (including two suicides) HRs (all non-signiﬁcant) were the
highest for HADS-D, then HADS-A and very low HRs for
GHQ-30. For mortality from ‘other’ causes, after full adjust-
ment, there was a signiﬁcant association with HADS-D only.
DISCUSSION
In the present analyses, comprising two cohorts, we found that
various measures of anxiety and depression were related to an
elevated risk of total and cause-speciﬁc mortalities. HADS-D
and GHQ-30 were similar in their relationships to all-cause,
CVD, and lack of relationship to cancer mortality. There were
some cause-speciﬁc differences in that after full adjustment the
only signiﬁcant HR for respiratory mortality was for GHQ-30
and for mortality from ‘other’ causes was for HADS-D. HRs for
HADS-A tended to be lower than that for the other measures.
For both HADS-D and GHQ-30, existing physical illness was
most important in attenuating the association with all-cause
mortality, followed by smoking.
Although a number of studies have found an association
between CMD and all-cause mortality,3–5 9 30–32 to our knowledge
no others have compared GHQ-30 and the HADS subscales in
this respect. Some studies have compared measures of anxiety and
depression and found as we do, that depression is a stronger pre-
dictor than anxiety31 while others found the opposite.9 The
HUNTstudy which used the HADS scale5 found, like us, a strong
association with HADS-D and all-cause mortality, but a non-linear
association for HADS-A, which we did not ﬁnd. We do not believe
this difference is due to our much longer follow-up since the pro-
portional hazards assumption held; however the HUNT study
included younger participants and they did ﬁnd an interaction
with age in some of their analyses, so the difference observed may
be due to the different ages in the two studies. The HUNT study
also found an association with anxiety only (ie, without comorbid
depression), adjusted for age, was signiﬁcant in men but not in
women which is consistent with our interaction between HADS-A
and sex.
In relation to cause-speciﬁc mortality, a review17 shows that
many studies ﬁnd that CMD predicts CVD morbidity, but there
are fewer studies of CMD predicting CVD mortality,3 4 9 30 32
and even fewer including more than one measure of CMD.6 9
The US military veterans study showed that depression pre-
dicted CVD mortality less strongly than anxiety,9 while another
study showed that HADS depression scores predicted CVD
mortality while HADS anxiety scores were protective.6 The ana-
lysis presented here showed that after full adjustment, HADS-D
and GHQ-30 had similar-sized HRs for CVD mortality and that
those for anxiety were smaller. Respiratory mortality was found
to be signiﬁcantly related to GHQ-30 and more weakly to
HADS-D in our analysis but this outcome has been included in
only a small number of studies.4 6 33 Consistent with this, one
study found that HADS-D score but not HADS-A score was
related to respiratory mortality6 and the OR was higher than
that for CVD mortality. Another study using the Present State
Examination33 found that depression predicted respiratory mor-
tality in women but this study did not adjust for any potential
confounders such as smoking. An analysis using UK Health and
Lifestyle Survey found that although GHQ-30 predicted respira-
tory mortality, this was explained by confounders and media-
tors.4 The lack of association between CMD and cancer
mortality is consistent with null or weak ﬁndings of other
studies3 4 33–36 although one study did ﬁnd a signiﬁcant associ-
ation between HADS-D alone (ie, without comorbid anxiety)
and cancer mortality.6 Relationships between mental illness and
cancer tend to be partially explained by pre-existing cancer,35 37
suggesting the relationships observed were partly due to the psy-
chological effect of the cancer diagnosis. Even before adjusting
for existing illness, we found very weak relationships between
CMD and cancer mortality, and with a very small number with
existing cancer (only 35 people), this may be why we found
such weak relationships. There were various strengths in this
study: more than one measure of CMD which is rarely avail-
able; a variety of covariates were measured, including those
recommended in the literature16: serious illness, smoking,
alcohol; the data were from a general rather than clinical popu-
lation and prevalence rates of anxiety and depression have been
shown to be similar to normative studies38; a long period of
follow-up; and there were data for both men and women.
There were also some limitations: 8% of the original sample
had missing data and were excluded; however, a sensitivity ana-
lysis showed no bias in the association between CMD and mor-
tality among those with missing covariates but available CMD
data. Although a good range of appropriate covariates were
included, it is possible that there is some omitted variable bias
or measurement error. For example, pulse had to be used in lieu
of physical activity, although this has been shown to be a good
proxy.29 There appears to be low power for causes other than
CVD and cancer due to fewer deaths. It is important to note
that neither HADS nor GHQ-30 scores represent clinical diag-
noses of mental disorders but are screening instruments.
The similarities between GHQ-30 and HADS-D in relation to
CVD mortality may be explained in both measures being
designed to measure symptoms typical of depression. Both
GHQ-30 and HADS were designed to be unaffected by physical
illness: adjusting for existing physical illness similarly attenuated
Table 2 HR per SD increase (95% CIs) for the association of GHQ and HADS scores with all-cause mortality
HR per SD increase (95% CIs)
All-cause (687 deaths) GHQ-30 HADS-A HADS-D
Model (1): adj sex, cohort 1.27 (1.16 to 1.39) 1.15 (1.06 to 1.26) 1.30 (1.21 to 1.41)
Model (2): adj (1)+serious illness 1.21 (1.11 to 1.33) 1.12 (1.02 to 1.22) 1.24 (1.14 to 1.35)
Model (3): adj (2)+social class 1.17 (1.07 to 1.28) 1.08 (0.99 to 1.18) 1.20 (1.10 to 1.30)
Model (4): adj (3)+smoking 1.13 (1.04 to 1.24) 1.04 (0.95 to 1.14) 1.16 (1.07 to 1.27)
Model (5): fully adjusted* 1.13 (1.04 to 1.23) 1.05 (0.96 to 1.14) 1.15 (1.07 to 1.25)
*Adjusted for sex, cohort, serious illness, social class, smoking, alcohol, obesity, pulse and living alone.
GHQ-30, 30-item General Health Questionnaire; HADS, Hospital Anxiety and Depression Scale.
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the HRs for GHQ-30 and HADS-D. There was also consistency
across measures in the ﬁnding of no relationship with cancer
mortality indicating no psychological link in this sample which
has a small number of cases of diagnosed cancer at baseline.
Although there were differences in signiﬁcance between
GHQ-30 and HADS-D for respiratory and ‘other’ mortality, the
HRs were not hugely different between the measures and low
power may be an explanation.
Various biological mechanisms linking CMD to CHD in
particular have been proposed24 25 including hypothalamic–
pituitary–adrenocortical (HPA) reactivity, diminished heart rate
variability, myocardial ischaemia, ventricular instability in reaction
to mental stress and alterations in platelet receptors. These could
explain the remaining association between all the measures of
CMD and CVD mortality after full adjustment. In relation to
respiratory mortality, it is possible that as well as inﬂuences on the
circulatory system,24 some of the same mechanisms could increase
the risk of infections in the lungs39 or hypoxia, lack of oxygen,
could affect mental health.40 It is important to note that although
the measures of CMD were related to mortality, it cannot be con-
cluded from this analysis that CMD causes mortality.
The similarities in the HRs for GHQ-30 and HADS-D in rela-
tion to all-cause and cause-speciﬁc mortality add strength to the
existing evidence of a relationship between mental health and
mortality, especially since recommended confounders and med-
iators were included in the analyses.
Future work in this area, including various causes of mortality
as outcomes, would be valuable, especially in larger studies.
What is already known on this subject?
▸ Many studies, including some using the General Health
Questionnaire (GHQ) or the Hospital Anxiety and Depression
Scale (HADS), show that people with common mental
disorders (CMD) have an increased risk of mortality.
▸ Differences have been found in how measures of depression
and anxiety predict mortality but results are not consistent
across studies and GHQ and HADS have not been compared
in this respect.
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What this study adds?
▸ There are remarkable similarities between GHQ-30 and
HADS depression in their association with all-cause and
cause-speciﬁc mortality.
▸ Various causes of mortality should be included as outcomes
in studies of CMD and mortality, especially in larger studies.
Table 3 HR per SD increase (95% CIs) for the association of GHQ and HADS scores with cause-specific mortality
HR per SD increase (95% CIs)
GHQ-30 HADS-A HADS-D
CVD (254 deaths)
Model (1): adj sex, cohort 1.44 (1.27 to 1.62) 1.30 (1.13 to 1.49) 1.46 (1.27 to 1.67)
Model (5): fully adjusted* 1.24 (1.11 to 1.40) 1.15 (1.01 to 1.32) 1.24 (1.07 to 1.43)
Respiratory (76 deaths)
Model (1): adj sex, cohort 1.52 (1.30 to 1.79) 1.27 (1.02 to 1.56) 1.42 (1.17 to 1.73)
Model (5): fully adjusted* 1.33 (1.13 to 1.55) 1.09 (0.89 to 1.33) 1.21 (0.99 to 1.48)
Cancer (250 deaths)
Model (1): adj sex, cohort 1.04 (0.90 to 1.21) 1.00 (0.85 to 1.16) 1.10 (0.97 to 1.26)
Model (5): fully adjusted a 0.95 (0.81 to 1.11) 0.92 (0.79 to 1.08) 1.00 (0.88 to 1.15)
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